Indications for the Use of Cytomegalovirus-Seronegative Blood Products
- 31 January 1991
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 5 (1) , 1-17
- https://doi.org/10.1016/s0887-7963(91)70189-2
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- Posttransfusion cytomegalovirus infection in neonates: Role of saline-washed red blood cellsThe Journal of Pediatrics, 1986
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysisThe Journal of Pediatrics, 1985
- MULTICENTER SEROEPIDEMIOLOGIC STUDY OF THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON RENAL TRANSPLANTATIONTransplantation, 1985
- Transfusion-Associated Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Sequelae of maternally derived cytomegalovirus infections in premature infantsThe Journal of Pediatrics, 1983
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981
- Cytomegaloviruria in older infants in intensive care nurseriesThe Journal of Pediatrics, 1979
- Cytomegaloviremia in children with acute lymphocytic leukemiaThe Journal of Pediatrics, 1975